UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
This regulatory filing was too large to post into our database. Please use the link below to view the original filing on the Securities and...
FORM 4 [ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
TABLE OF CONTENTS As filed with the U.S. Securities and Exchange Commission on December 20...
LONDON, Nov. 30, 2018 (GLOBE NEWSWIRE) -- In late November 2018, NetScientific (AIM: NSCI) announced that...
-Merger would create publicly-traded immuno-oncology biotechnology company developing novel products for...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM...
BERKELEY HEIGHTS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.